Cargando…

XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis

OBJECTIVES: Although platinum-based chemotherapy is widely used for advanced ovarian cancer (OC), genetic polymorphisms can influence the chemotherapeutic response. This study investigated the association between XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln, and overall survival (OS) in O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhuo, Xiang, Qian, Mu, Guangyan, Xie, Qiufen, Chen, Shuqing, Zhou, Shuang, Hu, Kun, Cui, Yi-min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250521/ https://www.ncbi.nlm.nih.gov/pubmed/30407287 http://dx.doi.org/10.1097/MD.0000000000012996

Ejemplares similares

Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis
por: Yu, Xin, et al.
Publicado: (2020)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis
por: Cui, Zhigang, et al.
Publicado: (2017)

3’UTR polymorphisms in NRAMP1 are associated with the susceptibility to pulmonary tuberculosis: A MOOSE-compliant meta-analysis
por: Liu, Yang, et al.
Publicado: (2019)

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
por: Sostelly, Alexandre, et al.
Publicado: (2019)

Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis
por: Wang, Fang-Ying, et al.
Publicado: (2019)

Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition
por: Xu, Manman, et al.
Publicado: (2022)

Association between ladybird homeobox 1 gene polymorphisms and adolescent idiopathic scoliosis: A MOOSE-compliant meta-analysis
por: Jiang, Hua, et al.
Publicado: (2019)

Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis
por: Zhang, Ningning, et al.
Publicado: (2020)

The association between transforming growth factor beta1 polymorphism and susceptibility to pulmonary fibrosis: A meta-analysis (MOOSE compliant)
por: Xin, Lili, et al.
Publicado: (2018)

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer
por: Storr, Sarah J, et al.
Publicado: (2012)

PyMOOSE: Interoperable Scripting in Python for MOOSE
por: Ray, Subhasis, et al.
Publicado: (2008)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

Associations between common ion channel single nucleotide polymorphisms and sudden cardiac death in adults: A MOOSE-compliant meta-analysis
por: Liu, Xiaoli, et al.
Publicado: (2018)

Gene locus polymorphisms and expression levels of interleukin-1 in lumbar disc disease: A MOOSE-compliant meta-analysis and immunohistochemical study
por: Yang, Kunxue, et al.
Publicado: (2022)

Migraine and breast cancer risk: a meta-analysis of observational studies based on MOOSE compliant
por: Wu, Xiujuan, et al.
Publicado: (2016)

Association between physical activity and risk of prevalent psoriasis: A MOOSE-compliant meta-analysis
por: Zheng, Qi, et al.
Publicado: (2018)

Combined effects of GSTM1 and GSTT1 polymorphisms on breast cancer risk: A MOOSE-compliant meta-analysis and false-positive report probabilities test
por: Miao, Li-Feng, et al.
Publicado: (2019)

Analyzing Association of the XRCC3 Gene Polymorphism with Ovarian Cancer Risk
por: Yuan, Cunzhong, et al.
Publicado: (2014)

Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis
por: Xie, Qiufen, et al.
Publicado: (2022)

Association between chemokine CXC ligand 12 gene polymorphism (rs1746048) and coronary heart disease: A MOOSE-compliant meta-analysis
por: Chen, Min, et al.
Publicado: (2017)

XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis
por: Shen, Xiao-yong, et al.
Publicado: (2013)

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
por: Li, Dan-Juan, et al.
Publicado: (2017)

Effectiveness and Safety of Platelet ADP–P2Y12 Receptor Inhibitors Influenced by Smoking Status: A Systematic Review and Meta‐Analysis
por: Liu, Zhiyan, et al.
Publicado: (2019)

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis
por: Yin, Supei, et al.
Publicado: (2016)

Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis
por: Liu, Wei, et al.
Publicado: (2019)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

The Moose project
por: Bos, Kors
Publicado: (1998)

XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer
por: Qiu, Mantang, et al.
Publicado: (2013)

XRCC1 gene polymorphisms and risk of neuroblastoma in Chinese children
por: Zhang, Jiao, et al.
Publicado: (2018)

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
por: Alblihy, Adel, et al.
Publicado: (2022)

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma
por: Liu, Yi, et al.
Publicado: (2021)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

A panel of three oxidative stress-related genes predicts overall survival in ovarian cancer patients received platinum-based chemotherapy
por: Zhang, Jin, et al.
Publicado: (2018)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

Contribution of the polymorphism rs1800469 of transforming growth factor β in the development of myocardial infarction: meta-analysis of 5460 cases and 8413 controls (MOOSE-compliant article)
por: Du, Ling, et al.
Publicado: (2019)

Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk
por: Yuan, Cunzhong, et al.
Publicado: (2020)

Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy
por: Yuan, Zhengrong, et al.
Publicado: (2015)

Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers
por: Ali, Reem, et al.
Publicado: (2021)

Hepatitis C virus infection is a risk factor for non-Hodgkin lymphoma: A MOOSE-compliant meta-analysis
por: Zhu, Xiaofeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pa4fq06nkk6ka66omr5j9minao